Apple’s smart watch has been a hot topic this week due to two events that marked the agenda of the Cupertina company. One of them is the project E5, future generations of devices will include integrating a glucose level measurement system.
Although companies Dexcom Inc. and Abbott Laboratories there are patches placed on the skin that replace the well-known fingertips, which need to be changed from time to time, Apple points to the use of special lasers that would avoid using the aforementioned methods to measure blood sugar levels..
(
Bloomberg explains that the method under study works with a chip technology known as silicon photonics and a measurement process called optical absorption spectroscopy. The system uses lasers to deliver specific wavelengths of light to an area under the skin where the interstitial fluid can be absorbed by glucose. The light is then reflected back to the sensor, showing the glucose concentration. An algorithm then determines the blood sugar level in the body.
One of these initiatives hidden It’s from Apple because, according to Bloomberg, the company with the bitten apple assigned fewer people to the project just announced than to the autonomous car overseen by the Special Projects Group or mixed reality headsets developed by the Technology Group. Development.
If successful, Apple could establish itself as a force in healthcare as it will be a useful device for diabetics. The US Centers for Disease Control and Prevention (CDC) states that more than 37 million people in the United States have diabetes; this is a factor the tech company may have already guessed.
(You may be interested: They are filtering the design of the iPhone 15 and this is the news it will bring)
But the Apple Watch is facing a challenge to prevent its commercialization in the North American country. Biden upheld a decision by the International Trade Commission (ITC) that could result. Apple Watch import ban.
This came about when the ITC decided in favor of AliveCor and Apple Watch infringed patents from a company called AliveCor that is directly involved in performing electrocardiograms from smartwatches.
Despite this, Bloomberg commented that news about glucose-measuring lasers caused Apple’s shares to rise compared to Abbott and Dexcom last Wednesday.
Source: Exame
